Eli Lilly and Co
XHAM:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XHAM:LLY
|
US |
|
C
|
Clorox Co
DUS:CXX
|
US |
|
D
|
DroneShield Ltd
OTC:DRSHF
|
AU |
|
Royal Bank of Canada
TSX:RY
|
CA |
|
F
|
Fujitsu Ltd
DUS:FUJ1
|
JP |
|
Adidas AG
F:ADS1
|
DE |
|
Global UAV Technologies Ltd
F:YAB
|
CA |
|
Mitsui & Co Ltd
OTC:MITSF
|
JP |
|
C
|
Carrefour SA
OTC:CRERF
|
FR |
|
A
|
argenx SE
SWB:1AE
|
NL |
|
Zurich Insurance Group AG
F:ZFI1
|
CH |
|
EssilorLuxottica SA
PAR:EL
|
FR |
|
Nongfu Spring Co Ltd
OTC:NNFSF
|
CN |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 1 037.84 EUR with a low forecast of 731.05 EUR and a high forecast of 1 341.18 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 037.84
EUR
According to Wall Street analysts, the average 1-year price target for LLY is 1 037.84 EUR with a low forecast of 731.05 EUR and a high forecast of 1 341.18 EUR.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.
